Government of Finland
Also known as: Academy of Finland | Academy of Finland (Risto O Roine) | Business Finland (National Innovation Agency) | Central Finland Hospital District | Centre for Military Medicine, Helsinki, Finland | City of Espoo | City of Tampere (Finland), Social and Health Services, Dental treatment | City of Turku | City of Vantaa | Department of Oncology, Vaasa Central Hospital, Vaasa, Finland | Dept of Otolaryngology, Kokkola Central Hospital, Finland | Heart Center, Pirkanmaa Hospitla District | Herttoniemi Hospital | Joint Authority for Päijät-Häme Social and Health Care | Kokkola Central Hospital, Finland | Kymeenlaakso Central Hospital | Kymenlaakso Central Hospital Kotka Finland | Lapland Central Hospital | Lapland Central Hospital Rovaniemi Finland | Laplnd Central Hospital Rovaniemi Finland | National Institute for Health and Welfare, Finland | National Istitute For Health and Welfare, Finland | North Carelia Central Hospital | North Karelia Central Hospital | Päijänne Tavastia Central Hospital | Pirkanmaa District Hospital | Pirkanmaa District Hospital, Department of Emergency Medicine | Pirkanmaa Hospital District, Tampere, Finland | Research Department, Centre for Military Medicine, Helsinki, Finland | Satakunta Central Hospital | Social services and Healthcare, City of Helsinki, Finland | South Karelia central hospital | The Laboratory and Pharmacy Public Utility of the Pirkanmaa Hospital District | Vaasa Central Hospital | Vaasa Central Hospital, Vaasa, Finland
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1994Last known activity
Jun 6, 2024
Timeline
1920s
- Jun 1, 1920
Government of Finland— Founded
Drugs by trial phase (85 distinct, 76 trials)
Phase 4 (40 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Alcoholism
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Atrial Fibrillation
- Basal Cell Carcinoma
- Brain Injuries
- Brain Ischemia
- Communicable Diseases
- Consciousness Disorders
- Contracture
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Digestive System Diseases
- Dupuytren Contracture
- Eczema
- Embolism
- Fractures, Bone
- Gambling
- Gastrointestinal Diseases
- Glaucoma
- Glaucoma, Open-Angle
- Growth Disorders
- Heart Arrest
- Heart Valve Diseases
- Hemorrhage
- Hutchinson's Melanotic Freckle
- Hypertension
- Hypothermia
- Infections
- Insulin Resistance
- Irritable Bowel Syndrome
- Ischemia
- Keratosis
- Keratosis, Actinic
- Lentigo
- Leukemia, Lymphocytic, Chronic, B-Cell
- Liver Failure
- Malaria
- Malnutrition
- Mastodynia
- Menorrhagia
- Multiple Myeloma
- Neoplasms, Basal Cell
- Neoplasms, Plasma Cell
- Obesity
- Ocular Hypertension
- Osteoarthritis
- Osteoarthritis, Hip
- Osteoporosis
- Otitis
- Otitis Media
- Pneumococcal Infections
- Postoperative Pain
- Pregnancy in Diabetics
- Premature Birth
- Prostatic Neoplasms
- Renal Insufficiency
- Respiratory Insufficiency
- Respiratory Sounds
- Respiratory Tract Infections
- Schizophrenia
- Sexually Transmitted Diseases
- Signs and Symptoms
- Sinusitis
- Still's Disease, Adult-Onset
- Stroke
- Thrombosis
Recent trials (50)
- NCT06523959CollaboratorPhase 4Jun 6, 2024
- NCT06282952CollaboratorN/AApr 1, 2024
- NCT06271551Lead sponsorPhase 2Mar 31, 2024
- NCT06210269CollaboratorN/AJan 31, 2024
- NCT05257538CollaboratorN/AAug 1, 2021
- NCT04696523CollaboratorPhase 2May 1, 2021
- NCT04731558CollaboratorPhase 4Feb 10, 2021
- NCT04687150CollaboratorN/AJan 31, 2021
- NCT04637438CollaboratorN/ANov 30, 2020
- NCT04026230CollaboratorPhase 3Aug 31, 2019
- NCT03765359CollaboratorPhase 4Jul 1, 2019
- NCT03235505Overall official - principal investigatorPhase 4Aug 1, 2018
- NCT03235505CollaboratorPhase 4Aug 1, 2018
- NCT03570450CollaboratorPhase 1Jun 2, 2018
- NCT03430180Overall official - principal investigatorPhase 2Feb 22, 2018
Details
- Founded
- Helsinki, FI Jun 1, 1920
- Last known activity
- Jun 6, 2024